Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagenTrypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissueThe role of SPINK1 in ETS rearrangement-negative prostate cancersSerum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancerA comprehensive nomenclature for serine proteases with homology to tissue kallikreinsUp-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the ratConformational and biochemical analysis of the cyclic peptides which modulate serine protease activity.Concomitant tumor expression of EGFR and TATI/SPINK1 associates with better prognosis in colorectal cancer.Novel peptide inhibitors of human kallikrein 2.SELDI-TOF MS versus prostate specific antigen analysis of prospective plasma samples in a nested case-control study of prostate cancer.Novel small molecule inhibitors for prostate-specific antigen.Absence of TGF-β Receptor Activation by Highly Purified hCG Preparations.Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patientsLoss of PTEN is associated with aggressive behavior in ERG-positive prostate cancerThe discovery of compounds that stimulate the activity of kallikrein-related peptidase 3 (KLK3).Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.Proteolytic activity of prostate-specific antigen (PSA) towards protein substrates and effect of peptides stimulating PSA activityProstate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP.Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer.Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer.Expression of human chorionic gonadotropin in testicular germ cell tumors.National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.Tumor-associated trypsin inhibitor.Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma.Human chorionic gonadotropin in cancer.Virtual Screening of Small Drug-Like Compounds Stimulating the Enzymatic Activity of Kallikrein-Related Peptidase 3 (KLK3).Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal AdenocarcinomaIndependent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancerPrognostic value of serum markers for prostate cancer.First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.The classification, functions and clinical use of different isoforms of HCG.Collagen degradation by tumor-associated trypsins.Prostate specific antigen for early detection of prostate cancer: longitudinal study.Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop.Antiangiogenic properties of prostate-specific antigen (PSA).
P50
Q24301276-0FE8195B-0141-48F2-853E-80F9FE984227Q24337189-DE7586C7-94C6-46D3-B0BE-C4E301A1E375Q24647020-CB51535B-6FAD-4295-9289-4D000A02BF1CQ28202441-F710913D-46A0-4E54-874A-41D0E8026E7CQ28248469-253CBF8E-58BB-4410-918F-F396A0B893E1Q28581561-F0D60C8B-6DED-4665-A0CC-F7DDB9E3BD63Q31105451-15422201-BB02-479C-96FD-237EAF82ABD1Q31143290-CE79CB8B-4524-4F69-85EB-98EA5A0BE968Q33235991-C239BDB3-7DA9-453C-AFDE-B8CB21A778E9Q33281227-6D3B6D31-BC7A-4AF1-B86C-ECC2162D0D05Q33337425-0864F2F7-3E93-44C0-87A0-6BAF6DA28C8EQ33631463-6304851F-519F-4F66-8237-3399CDD6FC31Q33694866-965A5A9C-45C1-49D5-B402-9934EEEA51E1Q33862890-F64EF927-B56D-458B-BBEA-BE5B2EF480ACQ34033411-48F89989-B6DC-4306-9482-75BC3D7D823CQ34041688-A5A073D8-46DC-4922-83E6-9A823C0EDFBEQ34215885-2B559695-0648-4CA3-BB2C-CC1951EB0134Q34283636-4ECC546D-3CFB-4DA9-AA5F-B0374DB7B27DQ34295127-4A770A03-FD7F-428B-91FA-6BC1A3978C0FQ34320166-4C70B8B8-5132-47C3-A2FA-5835BCB43454Q34339593-1B1FCC41-0CD4-4211-A8D5-3361A1931DF8Q34402838-80DC076E-F294-4619-B4E1-545700CACAA5Q34601116-4086A9B4-EC0A-4BD3-A4EE-10EA0D7D561BQ34653713-4DD177D8-1F80-402D-A21F-B1FFBDD6AD47Q34762695-13D4807C-1C60-4E11-91E1-512E95175C28Q35213711-A363A877-40C3-49EE-A7E1-90848E58EBD2Q35807891-AA06E2EF-601D-4681-8D5B-0DAF95BA74C1Q35826725-A822F43B-0BB6-472F-A2B1-B0E7239361E1Q36087908-18FD3385-797C-43E9-B26F-AF916DEC7A98Q36134440-886AD4CA-BD99-4A2C-9856-4CDE7379ED0EQ36136087-65490031-BE9B-46D5-85C2-4275C429971CQ36194964-9458FC68-FA68-492D-BED0-B834950E62C4Q36204185-06C4B69D-A190-4329-ACE3-B92E3E51ABD0Q36414170-14A19A11-8C28-47A6-BC8A-43D4163B1D6CQ36428301-5A3280B6-9486-4D59-94E2-2CFDF1CB54F9Q36551246-71FAD4EF-C6A5-42D3-A64D-137BF41E1BB6Q36931129-778508B5-ABF8-4EF6-A92C-56A3165BDEF3Q37362535-DDAD5E2C-B63F-4192-A9AC-9A7FB97231DAQ37381781-523D1832-27EB-4198-B335-324144F4A8D2Q37529537-45AE76CF-FAD3-43D9-A9E6-A2B265867F0C
P50
description
finländsk läkare
@sv
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Ulf-Håkan Stenman
@ast
Ulf-Håkan Stenman
@en
Ulf-Håkan Stenman
@es
Ulf-Håkan Stenman
@nl
Ulf-Håkan Stenman
@sl
Ulf-Håkan Stenman
@sv
type
label
Ulf-Håkan Stenman
@ast
Ulf-Håkan Stenman
@en
Ulf-Håkan Stenman
@es
Ulf-Håkan Stenman
@nl
Ulf-Håkan Stenman
@sl
Ulf-Håkan Stenman
@sv
prefLabel
Ulf-Håkan Stenman
@ast
Ulf-Håkan Stenman
@en
Ulf-Håkan Stenman
@es
Ulf-Håkan Stenman
@nl
Ulf-Håkan Stenman
@sl
Ulf-Håkan Stenman
@sv
P214
P106
P21
P213
0000 0001 1302 136X
P214
P31
P4854
StenmanUlfHaakan
P496
0000-0002-2695-3454
P569
1941-01-01T00:00:00Z
P7859
viaf-164920018